Provided by Tiger Trade Technology Pte. Ltd.

Caribou Biosciences

0.6174
-0.5176-45.60%
Post-market: 0.6100-0.0074-1.20%16:24 EDT
Volume:36.95M
Turnover:22.88M
Market Cap:66.06M
PE:-0.57
High:0.6700
Open:0.6360
Low:0.5460
Close:1.14
52wk High:3.54
52wk Low:0.5460
Shares:107.00M
Float Shares:102.16M
Volume Ratio:18.69
T/O Rate:36.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0751
EPS(LYR):-1.5900
ROE:-78.27%
ROA:-36.84%
PB:0.67
PE(LYR):-0.39

Loading ...

Caribou Biosciences - to Discontinue Vispa-Cel and CB-011 CAR-T Cell Therapy Programs

THOMSON REUTERS
·
Yesterday

Caribou Biosciences - to Implement Workforce and Cost Reductions

THOMSON REUTERS
·
Yesterday

NASDAQ Trade Halt Halt News Pending at 04:01 Pm

Reuters
·
Yesterday

Lytix Biopharma Names Timothy Herpin Chief Business Officer

Reuters
·
Aug 18

Caribou Biosciences is Maintained at Buy by B of a Securities

Dow Jones
·
Aug 15

BofA Adjusts Price Target on Caribou Biosciences to $5 From $6

MT Newswires Live
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Caribou Biosciences (CRBU) and Aveanna Healthcare Holdings (AVAH)

TIPRANKS
·
Aug 14

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrodinger (SDGR)

TIPRANKS
·
Aug 14

Caribou Biosciences Q2 Basic EPS USD -0.24

THOMSON REUTERS
·
Aug 14

Caribou Biosciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Caribou Biosciences Q2 EPS $(0.24) Beats $(0.32) Estimate, Sales $1.499M Miss $2.279M Estimate

Benzinga Earnings
·
Aug 14

Caribou Biosciences Q2 FY26 GAAP Net Loss Narrows to USD 24.3 Million; Revenue Falls to USD 1.5 Million

Reuters
·
Aug 14

Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 14

Caribou Biosciences, Inc. Expected to Post a Loss of 32 Cents a Share - Earnings Preview

Reuters
·
Aug 12

Caribou Biosciences Inc Expected to Post a Loss of 32 Cents a Share - Earnings Preview

Reuters
·
Aug 01

Caribou Biosciences CEO Joins H.C. Wainwright Cell Therapy Conference Fireside Chat

Reuters
·
Jun 29

Caribou Biosciences Shareholders Decide Key Governance Matters

TIPRANKS
·
Jun 19

Caribou Biosciences shareholders reject officer exculpation charter amendment at annual meeting

Reuters
·
Jun 19

Caribou Biosciences: Buy Rating Reaffirmed on Advancing Allogeneic CAR-T Pipeline and EHA Data; $6 Price Target Maintained

TIPRANKS
·
Jun 12

Caribou Biosciences presents ANTLER trial results at EHA

TIPRANKS
·
Jun 11